Design, execution, and analysis of pooledin vitroCRISPR/Cas9 screens-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Design, execution, and analysis of pooledin vitroCRISPR/Cas9 screens

Published:2016-06-16 Issue:17 Volume:283 Page:3170-3180
ISSN:1742-464X
Container-title:The FEBS Journal
language:en
Short-container-title:FEBS J

Author:

Miles Linde A.¹,Garippa Ralph J.²,Poirier John T.³⁴⁵

Affiliation:

1. Pharmacology Graduate Training Program; Department of Pharmacology and Molecular Sciences; Johns Hopkins University; Baltimore MD USA

2. RNAi Core Facility; Memorial Sloan-Kettering Cancer Center; New York NY USA

3. Department of Medicine; Memorial Sloan Kettering Cancer Center; New York NY USA

4. Molecular Pharmacology Program; Memorial Sloan Kettering Cancer Center; New York NY USA

5. Weill Cornell Medical College; New York NY USA

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/febs.13770/fullpdf

Reference42 articles.

1. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells;Elbashir;Nature,2001

2. A resource for large-scale RNA-interference-based screens in mammals;Paddison;Nature,2004

3. Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification;Deans;Nat Chem Biol,2016

4. Systematic comparison of CRISPR/Cas9 and RNAi screens for essential genes;Morgens;Nat Biotechnol,2016

5. CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes;Evers;Nat Biotechnol,2016

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revitalizing oral cancer research: Crispr-Cas9 technology the promise of genetic editing;Frontiers in Oncology;2024-06-10

2. Advances in CRISPR-Cas systems for blood cancer;Progress in Molecular Biology and Translational Science;2024

3. Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival;Cell Communication and Signaling;2023-11-16

4. Drug Repurposing to Circumvent Immune Checkpoint Inhibitor Resistance in Cancer Immunotherapy;Pharmaceutics;2023-08-21

5. Optimized whole-genome CRISPR interference screens identify ARID1A-dependent growth regulators in human induced pluripotent stem cells;Stem Cell Reports;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3